Premium
P3‐310: The requirement to learn amyloid status is not a barrier to enrollment in preclinical Alzheimer's disease clinical trials
Author(s) -
Grill Joshua D.,
Zhou Yan,
Elashoff David,
Karlawish Jason
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.1684
Subject(s) - medicine , clinical trial , disease , biomarker , informed consent , randomized controlled trial , surrogate endpoint , oncology , physical therapy , pathology , alternative medicine , biochemistry , chemistry